This is just a quick blog post to let you know of some of our recently revised checklists
Alemtuzumab neurological complications
Anti MOG antibody disease treatment
Cavernomas clinical features
Cenobamate
Cerebral amyloid angiopathy related inflammation (CAA-ri)
***
CIDP clinical features
Cluster headache acute treatment
Dravet syndrome management
Duchenne muscular dystrophy genetic treatments
Functional neurological disorders (FND)
***
Inclusion body myositis (IBM) risk factors
Intracerebral haemorrhage (ICH) prognosis
Migraine prophylactic drugs
Metastatic cord compression
Myasthenia gravis (MG) non-steroid immunosuppression
***
Myelopathy with normal MRI scans
Neurology of organ transplantation
POEMS syndrome
Pompe disease investigations
Radiotherapy and the nervous system
***
Spinal muscular atrophy (SMA) gene therapy
Stroke early neurological deterioration
Subarachnoid haemorrhage (SAH) vasospasm
Supranuclear gaze palsy
Transient smartphone blindness (TSB)
***
